You are here: Industry Insights > vaccine

News List

Merck moves up sales rankings in vaccine industry projection fiercepharma
July 05, 2017
Last year, life science commercial intelligence firm Evaluate released a vaccine market projection stating that GlaxoSmithKline would top the industry by 2022, with Sanofi, Pfizer and Merck trailing in order.
Major advancement in cell-based influenza vaccine technology by Seqirus biospectrumasia
June 26, 2017
Seqirus has successfully produced cell-based influenza vaccine at commercial scale using a candidate vaccine virus (CVV) that has been isolated and grown in cells, rather than in eggs
Florida congressional members want U.S. Army to hold public hearings on Zika vaccine newsnow
June 15, 2017
Florida congressional members want U.S. Army to hold public hearings on Zika vaccine.
Cancer vaccine developer Targovax pulls in €21M in private placement fiercepharma
June 14, 2017
Norwegian biotech Targovax has raised about €21 million in a private placement as it works to advance prostate cancer vaccine TG01 and other programs against a variety of cancers.
Vaccine Blocks Drug Heroin High in Tests on Monkeys drugs
June 08, 2017
a vaccine designed to block a heroin "high" worked in monkeys
Vaccine Blocks Drug Heroin High in Tests on Monkeys drugs.com
June 08, 2017
A vaccine designed to block a heroin "high" worked in monkeys, which could open the door to human clinical trials, researchers say.
Vetter, Microdermics Enter Strategic Drug Delivery Alliance contractpharma
June 01, 2017
To develop microneedle drug delivery systems
Shareholder suit targets NewLink management over failed cancer vaccine trial fiercepharma
May 25, 2017
A year after NewLink Genetics reported a phase 3 trial failure for its pancreatic cancer vaccine that crushed shares, a shareholder is taking it to the company’s current and former execs for “gross mismanagement” and other allegations.
Inovio’s NIH-backed HIV vaccine shows near 100% immune response rate in early test fiercepharma
May 25, 2017
Inovio is one step closer in the race to create an effective HIV vaccine. Data from an early-stage clinical study showed that its Pennvax-GP could elicit an immune response in nearly all participants.
Limited domestic vaccine manufacturing endangers U.S. flu prep, GAO report says fiercepharma
May 18, 2017
The U.S. could run into a vaccine supply predicament if an influenza pandemic hits, since only one drugmaker has a U.S. facility with egg-based vaccine production capabilities.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 100 101 Next page